Margaret Wilson
Family Medicine · Kirksville, MONPI 1720064413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $342 and has fallen 53.4% since, to $160 in 2025.
Across 78 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$163
- Lilly USA, LLC$139
- Abbott$126
- Dexcom, Inc.$111
- AbbVie$85
- AstraZeneca$74
- plus $527 from 18 others
What the payments were for
- Food & beverage$1,226100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $163 |
| Lilly USA, LLC | 8 | $139 |
| Abbott | 7 | $126 |
| Dexcom, Inc. | 5 | $111 |
| AbbVie(2 entities) | 6 | $85 |
| AstraZeneca | 5 | $74 |
| Bayer | 4 | $66 |
| Johnson & Johnson | 4 | $61 |
| Pfizer | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 3 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Merck | 2 | $28 |
| Amgen | 2 | $26 |
| Viatris Specialty LLC | 1 | $22 |
| Resmed Corp | 1 | $20 |
| Ardelyx, Inc. | 1 | $15 |
| Melinta Therapeutics, LLC | 2 | $14 |
| Exact Sciences | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Mylan Specialty L.p. | 1 | $12 |
| Novartis | 1 | $11 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
How this compares
$1,226 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 66 | $562 |
| Amlodipine Besylate | 55 | $541 |
| Levothyroxine Sodium | 87 | $460 |
| Leflunomide | 26 | $405 |
| Atorvastatin Calcium | 33 | $386 |
| Lovastatin | 66 | $359 |
| Paroxetine Hcl | 20 | $326 |
| Potassium Chloride | 13 | $295 |
| Lisinopril | 31 | $254 |
| Alendronate Sodium | 39 | $241 |
| Metoprolol Succinate | 21 | $168 |
| Metformin Hcl | 12 | $159 |
| Hydrochlorothiazide | 37 | $153 |
| Losartan Potassium | 19 | $142 |
| Tramadol Hcl | 30 | $142 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Kirksville
- Justin PuckettKirksville$568K
- Steven LyonsKirksville$15K
- Stephen AdamsSpringfield$636K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.